Clinical Trial Update: Predictive Multimodal Signatures Associated With Response to Treatment and Prognosis of Patients With Stage IV Non-small Cell Lung Cancer

View source ↗

Summary

Clinical trial update describing predictive multimodal signatures linked to treatment response and prognosis in patients with stage IV non-small cell lung cance…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Sophia Genetics SAS | Conditions: Non-small Cell Lung Cancer Metastatic | Status: ACTIVE_NOT_RECRUITING